The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
peng ti zuo mi lian he jia po ni long zhi liao fu fa / nan zhi xing duo fa xing gu sui liu de liao xiao guan cha
Author(s): 
Pages: 585-586
Year: Issue:  7
Journal: Chinese Journal of Internal Medicine

Abstract: 多发性骨髓瘤(MM)是一种常见的血液系统恶性肿瘤,近年来发病率呈逐渐上升趋势.MM目前仍然不能被治愈,初发患者经治疗后多数演变为复发/难治性,治疗困难,预后差.硼替佐米作为一种新型的生物靶向治疗药物在MM的治疗中取得了较好的疗效,特别是对复发/难治性病例,明显优于传统化疗[1].我们应用硼替佐米联合甲泼尼龙治疗20例复发/难治性MM,取得较好疗效.……
Related Articles
No related articles found